Fmoc-2-Trifluoromethyl-D-Phenylalanine

Fmoc-2-Trifluoromethyl-D-Phenylalanine is an Fmoc-protected, D-configured phenylalanine derivative bearing a stereogenic alpha carbon and a side chain substituted with a trifluoromethyl group at the ortho position relative to the benzylic linkage. The molecule combines an aromatic ring system with a strongly electron-withdrawing CF3 substituent, which modulates amide-bond formation reactivity and downstream physicochemical properties such as hydrophobicity and metabolic stability. The Fmoc group provides a base-labile N-protection handle for solid-phase peptide synthesis and supports orthogonal deprotection strategies when paired with acid-stable side-chain protections. The chiral, fluorinated amino acid scaffold functions as a chemically defined intermediate for peptide building block preparation and for constructing fluorinated peptidomimetics with controlled stereochemistry.

1. Peptide Synthesis

Fmoc-2-Trifluoromethyl-D-Phenylalanine is suitable for peptide building block preparation in automated solid-phase peptide synthesis workflows where the Fmoc-protected N-terminus enables stepwise coupling and subsequent base-mediated deprotection. The D-configuration at the alpha carbon supports stereochemically defined incorporation into peptide sequences, while the ortho-trifluoromethyl phenyl side chain can influence local conformational preferences and aromatic packing in the growing chain. The aromatic/CF3 functional pattern can participate in standard peptide coupling chemistry via activation of the carboxylate to form the corresponding amide linkage. The resulting fluorinated D-amino acid-containing peptides can be used as research-grade constructs for structure-function studies and as intermediates toward peptidomimetic scaffolds.

2. Peptidomimetics And SAR

Fmoc-2-Trifluoromethyl-D-Phenylalanine is applied in peptidomimetic construction and structure-activity relationship studies where fluorinated aromatic side chains help tune lipophilicity, electronic distribution, and steric profiles. The CF3-substituted phenyl ring provides a defined hydrophobic and electron-withdrawing motif that can be systematically varied across analog libraries while maintaining the same backbone stereochemistry. The Fmoc-protected amino acid format supports consistent incorporation into peptide-like frameworks, enabling comparative SAR workflows that rely on controlled stereochemical placement of D-amino acid residues. Downstream derivatives prepared from these constructs can include truncated analogs, cyclization precursors, or side-chain-modified variants that retain the fluorinated aryl pharmacophore.

3. Chemical Biology Probes

Fmoc-2-Trifluoromethyl-D-Phenylalanine supports chemical biology research through incorporation into labeled or affinity-tagged peptide probes where a fluorinated aromatic residue can serve as a stable recognition element. The D-configuration can be leveraged to modulate protease resistance and alter binding behavior of peptide-based probes without changing the protected backbone chemistry required for coupling. The Fmoc group enables preparation of probe peptides with controlled N-terminal identity, while the CF3-bearing aromatic side chain can enhance hydrophobic interactions relevant to biomolecular recognition. The resulting fluorinated peptide probes can be used as intermediates for generating biomolecule-interacting reagents, including conjugation-ready sequences that withstand harsh synthetic steps.

4. Chiral Building Block Synthesis

Fmoc-2-Trifluoromethyl-D-Phenylalanine functions as a chiral amino acid intermediate for stereoselective synthesis routes that require a defined D-phenylalanine stereocenter and an ortho-CF3 substituted aromatic side chain. The presence of the Fmoc-protecting group standardizes the N-protection state for downstream transformations, allowing the compound to be handled as a consistent chiral building block in fine chemical synthesis. The CF3 substituent provides a chemically robust substituent that can survive multiple peptide assembly and purification conditions while maintaining strong electronic effects in the final products. The compound can be employed to generate enantiomerically defined fluorinated amino acid derivatives and peptide fragments used in method development and stereochemical validation studies.

5. Pharmaceutical Intermediate Preparation

Fmoc-2-Trifluoromethyl-D-Phenylalanine is relevant to pharmaceutical intermediate preparation where fluorinated D-amino acid residues are incorporated into peptide-like candidates or key intermediates for medicinal chemistry programs. The Fmoc-protected amino acid format supports scalable peptide coupling chemistry and provides a protected handle for controlled deprotection during manufacturing-oriented synthesis planning. The carboxylate and protected amine enable conversion into amide-containing intermediates, while the CF3-substituted aromatic side chain contributes to physicochemical tuning that can be carried through to later process steps. Downstream products derived from this intermediate can include protected peptide fragments, cyclization precursors, or final fluorinated peptidomimetic building blocks used in applied product development workflows.

6. Process Chemistry Intermediate

Fmoc-2-Trifluoromethyl-D-Phenylalanine is suitable for process chemistry intermediate preparation where stable, isolable protected amino acid forms are required for reliable manufacturing-scale peptide assembly. The Fmoc group supports base-labile deprotection control, which can be integrated into orthogonal protection schemes during multistep synthesis of fluorinated peptide intermediates. The D-stereocenter and CF3-substituted aromatic side chain provide a defined structural motif that can be carried through purification and coupling steps with minimal ambiguity in stereochemical identity. The compound can be employed to produce fluorinated peptide fragments and peptidomimetic intermediates that serve as feedstocks for further derivatization, including sequence extension, fragment coupling, and final functional group installation.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells